Mozambique ARV plant by 2010; illegal imports
The President of Mozambique, Armando Guebuza, has announced the opening of an antiretroviral drug manufacturing plant in Maputo by 2010. The facility was first proposed with Brazilian funding in 2003 but has been held up by local difficulties, according to the national news agency, Agencia de Informacao de Mocambique.
Pres Guebuza was speaking at a state banquet for the visit of Brazil's President Luis Inacio Lula da Silva in Mozambique's capital. The two leaders also attended the opening of the Brazilian Oswaldo Cruz Foundation's (FIOCRUZ) offices in Maputo, the organization which will be setting up the ARV production center. About 1.5 million Mozambicans are estimated to be HIV positive, with the number of people receiving treatment rising from 6,000 in 2005 to over 100,000 at present, according to official sources.
Illegally imported drugs seized
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze